Statement from FDA on continuing efforts to maintain its strong oversight of generic drugs
date:Feb 25, 2019
the FDAs approval before the manufacturer can distribute the drug product. Overseeing how drugs are produced is a key component of ensuring their ongoing quality and safety.

After marketing of a drug, we also maintain active safety pharmacovigilance, particularly to identify and evaluate previously unreported adverse events (more commonly known as side effects). In most cases, one cannot draw a causal relationship from adverse event reports alone. Its also generally not possible to determine wh
12/35 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/18 22:10